California Public Employees Retirement System Portfolio holdings
The California Public Employees’ Retirement System (CalPERS), established in 1932 and headquartered in Sacramento, California, is the largest public pension fund in the U.S., managing over $510 billion in assets as of late 2024 to provide retirement and health benefits to more than 2 million state and local government employees, retirees, and their families. Operating as a defined benefit plan, CalPERS invests globally across equities, fixed income, real estate, private equity, and infrastructure, guided by a 13-member board and a commitment to sustainable investing and ESG (environmental, social, governance) principles under Chief Investment Officer Ben Meng since 2024. Known for its influential shareholder activism—pushing for corporate governance reforms—CalPERS serves over 3,000 employers, including state agencies and school districts, balancing long-term funding needs with a $100 billion unfunded liability challenge. As a cornerstone of California’s public sector, it blends financial stewardship with a mission to secure retiree livelihoods.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$473M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$433M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$371M |
| 4 |
Adobe
ADBE
|
+$284M |
| 5 |
RTX Corp
RTX
|
+$200M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$316M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$139M |
| 3 |
Sysco
SYY
|
+$139M |
| 4 |
AGN
Allergan plc
AGN
|
+$134M |
| 5 |
Welltower
WELL
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.15% |
| 2 | Healthcare | 14.75% |
| 3 | Financials | 12.89% |
| 4 | Consumer Discretionary | 10.68% |
| 5 | Consumer Staples | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Kura Oncology
KURA
$957M
| $1.91M | ﹤0.01% |
117,314
+40,860
| +53% | +$589K |
|
1827
Health Catalyst
HCAT
$139M
| $1.91M | ﹤0.01% |
65,300
+56,800
| +668% | +$1.57M |
|
1828
Primoris Services
PRIM
$4.46B
| $1.91M | ﹤0.01% |
107,259
+6,467
| +6% | +$102K |
|
|
LADR
1829
Ladder Capital
LADR
$1.27B
| $1.9M | ﹤0.01% |
234,275
-500
| -0.2% | -$3.75K |
|
1830
Interparfums
IPAR
$3.67B
| $1.89M | ﹤0.01% |
39,334
+100
| +0.3% | +$4.5K |
|
|
VBTX
1831
DELISTED
Veritex Holdings
VBTX
| $1.89M | ﹤0.01% |
106,780
-3,449
| -3% | -$56K |
|
1832
BGC Group
BGC
$5.28B
| $1.89M | ﹤0.01% |
689,029
+21,080
| +3% | +$58.4K |
|
1833
Usana Health Sciences
USNA
$249M
| $1.88M | ﹤0.01% |
25,582
-2,380
| -9% | -$187K |
|
1834
TTEC Holdings
TTEC
$78.4M
| $1.87M | ﹤0.01% |
40,204
+6,808
| +20% | +$272K |
|
1835
Travere Therapeutics
TVTX
$5.85B
| $1.87M | ﹤0.01% |
91,549
-500
| -0.5% | -$7.96K |
|
|
KDMN
1836
DELISTED
Kadmon Holdings, Inc.
KDMN
| $1.87M | ﹤0.01% |
365,044
+15,288
| +4% | +$68.5K |
|
|
TBIO
1837
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $1.86M | ﹤0.01% |
104,086
+49,081
| +89% | +$740K |
|
1838
Intellia Therapeutics
NTLA
$1.64B
| $1.86M | ﹤0.01% |
88,700
+9,900
| +13% | +$168K |
|
|
TCS
1839
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $1.85M | ﹤0.01% |
38,060
-193
| -0.5% | -$7.45K |
|
1840
Stratasys
SSYS
$773M
| $1.84M | ﹤0.01% |
115,838
+977
| +0.9% | +$16.5K |
|
|
NP
1841
DELISTED
Neenah, Inc. Common Stock
NP
| $1.83M | ﹤0.01% |
37,065
-736
| -2% | -$35.4K |
|
1842
Arcus Biosciences
RCUS
$3.71B
| $1.83M | ﹤0.01% |
74,065
+8,194
| +12% | +$221K |
|
|
SWI
1843
DELISTED
SolarWinds Corporation Common Stock
SWI
| $1.83M | ﹤0.01% |
98,310
+3,173
| +3% | +$58.5K |
|
1844
Futu Holdings
FUTU
$14.7B
| $1.83M | ﹤0.01% |
+77,312
| New | +$1.16M |
|
|
LTHM
1845
DELISTED
Livent Corporation
LTHM
| $1.83M | ﹤0.01% |
296,900
-2,097
| -0.7% | -$13.2K |
|
1846
New Mountain Finance
NMFC
$732M
| $1.83M | ﹤0.01% |
196,600
+14,600
| +8% | +$120K |
|
1847
First Commonwealth Financial
FCF
$2.19B
| $1.82M | ﹤0.01% |
220,468
-867
| -0.4% | -$7.31K |
|
|
CNST
1848
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $1.82M | ﹤0.01% |
60,661
+24,703
| +69% | +$890K |
|
1849
CEVA Inc
CEVA
$913M
| $1.82M | ﹤0.01% |
48,626
+309
| +0.6% | +$9.91K |
|
1850
Benchmark Electronics
BHE
$2.92B
| $1.81M | ﹤0.01% |
84,007
-2,203
| -3% | -$46.2K |
|
Similar funds
California Public Employees Retirement System's Q2 2020 Portfolio in Review
As of Q2 2020, California Public Employees Retirement System held 3,550 positions worth $101B, up 23% from $82.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
California Public Employees Retirement System deployed $3.3B of net new capital in Q2 2020, opening 169 new positions and adding to 1,761 existing holdings. Its largest new stake was RTX Corp: 3,200,810 shares worth $197M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Apple, an estimated $316M trimmed.
- California Public Employees Retirement System's largest Q2 2020 buy was RTX Corp: 3,200,810 shares worth $197M.
- California Public Employees Retirement System added most to Gilead Sciences in Q2 2020, an estimated $473M increase.
- California Public Employees Retirement System's biggest Q2 2020 reduction was Apple, cutting an estimated $316M.
- California Public Employees Retirement System fully exited Allergan plc in Q2 2020, selling an estimated $134M.
- California Public Employees Retirement System's ten largest holdings make up 18% of its $101B portfolio in Q2 2020.
- California Public Employees Retirement System opened 169 new positions and closed 43 in Q2 2020.
- California Public Employees Retirement System's portfolio value rose 23% quarter-over-quarter to $101B.
Based on California Public Employees Retirement System's 13F filing for Q2 2020, filed 12 Aug 2020.